High expression of TIG3 predicts poor survival in patients with primary glioblastoma-Reference-Cited by-同舟云学术

High expression of TIG3 predicts poor survival in patients with primary glioblastoma

Published:2017-06 Issue:6 Volume:39 Page:101042831771213
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumour Biol.

Author:

Wang Hongxiang¹,Xu Hanchong¹,Xu Tao¹,Tan Cong²,Jiang Mei³,Chen Yihong⁴,Hu Xinyu³,Zhou Jinxu¹⁵,Shen Junyan³,Qin Rong¹⁶,Hu Daiyu³,Huang Qilin¹,Wang Min³,Wang Lian³,Duan Dongxia³,Yan Yong¹,Chen Juxiang¹

Affiliation:

1. Department of Neurosurgery, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China

2. Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China

3. Department of Regenerative Medicine, Tongji University School of Medicine, Shanghai, China

4. Department of Cardiology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China

5. Department of Neurosurgery, The 101th Hospital of PLA, Wuxi, China

6. Department of Neurosurgery, The 184th Hospital of PLA, Yingtan, China

Publisher

IOS Press

Subject

General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1010428317712135

Reference41 articles.

1. Glioblastoma and Other Malignant Gliomas

2. Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma

3. Malignant Gliomas in Adults

4. The Challenges and the Promise of Molecular Targeted Therapy in Malignant Gliomas

5. Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phospholipase A and acyltransferase 4/retinoic acid receptor responder 3 at the intersection of tumor suppression and pathogen restriction;Frontiers in Immunology;2023-03-31

2. Phospholipase A/acyltransferase 4 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer;Heliyon;2022-09